References Question 1
- Balagula Y, et al. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. Int J Dermatol. 2011;50(2):129-46.
- Hu J, et al. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J Am Acad Dermatol. 2007;56(2):317-26.
- Bolognia J et al. (2012). Dermatology. Philadelphia: Elsevier Saunders.
- Joshi S, et al. Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life. Cancer. 2010;116(16):3916-23.
References Question 2
- Menko F et al. European BHD consortium. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009 ; 10(12) :1199-206.
- Bolognia J et al. (2012). Dermatology. Philadelphia: Elsevier Saunders.
- Elston D et al. (2014). Dermatopathology. Philadelphia: Elsevier Saunders.
- Kniffin C, McKusick V. OMIM#135150: Birt-Hogg-Dube syndrome. OMIM- Online Mendelian Inheritance in Man. http:// omim.org/entry/135150. Accessed September 2018.
- Trufant J, et al. Brooke-Spiegler syndrome. Dermatol Online J. 2012;18(12):16.
- Hamosh A, McKusick V. OMIM#158350: Cowden syndrome 1. OMIM- Online Mendelian Inheritance in Man. http://omim. org/entry/158350. Accessed September 2018.
- Fuji K, Miyashita T. Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review. Pediatr Int. 2014;56:667-74.
References Question 3
- Schlosser BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010 May-Jun. 23(3):251-67.
